TRIM47 increases p53 ubiquitination and degradation by interacting with p53 protein, thus promoting the malignant biological behavior of renal cell carcinoma (Table 1) (Supplementary Table S1) (Chen et al., 2021). Here, TP53 is linked to hereditary clear cell renal cell carcinoma.